108 related articles for article (PubMed ID: 10581371)
21. Visual and brainstem auditory evoked potentials in hereditary motor-sensory neuropathy.
Kowalski JW; Rasheva M; Zakrzewska B
Electromyogr Clin Neurophysiol; 1991 Apr; 31(3):167-72. PubMed ID: 2049992
[TBL] [Abstract][Full Text] [Related]
22. Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Kiiski HS; Ní Riada S; Lalor EC; Gonçalves NR; Nolan H; Whelan R; Lonergan R; Kelly S; O'Brien MC; Kinsella K; Bramham J; Burke T; Ó Donnchadha S; Hutchinson M; Tubridy N; Reilly RB
PLoS One; 2016; 11(1):e0146084. PubMed ID: 26726800
[TBL] [Abstract][Full Text] [Related]
23. Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment.
La Mantia L; Riti F; Milanese C; Salmaggi A; Eoli M; Ciano C; Avanzini G
Ital J Neurol Sci; 1994 Oct; 15(7):333-40. PubMed ID: 7698890
[TBL] [Abstract][Full Text] [Related]
24. Electroencephalography, evoked potentials and MRI brain scans in saturation divers. An epidemiological study.
Todnem K; Skeidsvoll H; Svihus R; Rinck P; Riise T; Kambestad BK; Aarli JA
Electroencephalogr Clin Neurophysiol; 1991 Oct; 79(4):322-9. PubMed ID: 1717236
[TBL] [Abstract][Full Text] [Related]
25. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
26. Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.
Boster A; Caon C; Perumal J; Hreha S; Zabad R; Zak I; Tselis A; Lisak R; Khan O
Mult Scler; 2008 Jul; 14(6):804-8. PubMed ID: 18573830
[TBL] [Abstract][Full Text] [Related]
27. Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients.
Gazioglu S; Boz C
Clin Neurophysiol; 2012 Sep; 123(9):1872-9. PubMed ID: 22418590
[TBL] [Abstract][Full Text] [Related]
28. No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS.
Pisa M; Guerrieri S; Di Maggio G; Medaglini S; Moiola L; Martinelli V; Comi G; Leocani L
Neurology; 2017 Dec; 89(24):2469-2475. PubMed ID: 29142087
[TBL] [Abstract][Full Text] [Related]
29. T2 lesions and rate of progression of disability in multiple sclerosis.
Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of multimodal evoked potentials in the determination of subclinical neurological involvement of Wilson's disease.
Ecevit C; Ozgenç F; Gökçay F; Celebisoy N; Baran M; Yağci RV
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):627-32. PubMed ID: 22433793
[TBL] [Abstract][Full Text] [Related]
31. Evoked potential findings in Behçet's disease. Brain-stem auditory, visual, and somatosensory evoked potentials in 44 patients.
Stigsby B; Bohlega S; al-Kawi MZ; al-Dalaan A; el-Ramahi K
Electroencephalogr Clin Neurophysiol; 1994 Jul; 92(4):273-81. PubMed ID: 7517849
[TBL] [Abstract][Full Text] [Related]
32. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Brainstem Auditory Evoked Potentials Scoring in Evaluating Brainstem Dysfunction and Disability Among Individuals With Multiple Sclerosis.
Srinivasan VS; Krishna R; Munirathinam BR
Am J Audiol; 2021 Jun; 30(2):255-265. PubMed ID: 33769865
[TBL] [Abstract][Full Text] [Related]
34. Visual and brainstem auditory evoked potentials in infants with severe vitamin B12 deficiency.
Demir N; Koç A; Abuhandan M; Calik M; Işcan A
Turk J Med Sci; 2015; 45(6):1274-9. PubMed ID: 26775382
[TBL] [Abstract][Full Text] [Related]
35. Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300).
Nakao M; Barsky AJ; Nishikitani M; Yano E; Murata K
Neurosci Lett; 2007 Mar; 415(2):185-9. PubMed ID: 17267120
[TBL] [Abstract][Full Text] [Related]
36. Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites.
Muthane UB; Satishchandra P; Subhash MN
Mov Disord; 1993 Jul; 8(3):344-8. PubMed ID: 7688076
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Chirapapaisan N; Laotaweerungsawat S; Chuenkongkaew W; Samsen P; Ruangvaravate N; Thuangtong A; Chanvarapha N
Doc Ophthalmol; 2015 Feb; 130(1):25-30. PubMed ID: 25330954
[TBL] [Abstract][Full Text] [Related]
38. Evoked potentials and EEG in multiple sclerosis.
Pakalnis A; Drake ME; Dadmehr N; Weiss K
Electroencephalogr Clin Neurophysiol; 1987 Oct; 67(4):333-6. PubMed ID: 2441967
[TBL] [Abstract][Full Text] [Related]
39. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
Pelayo R; Montalban X; Minoves T; Moncho D; Rio J; Nos C; Tur C; Castillo J; Horga A; Comabella M; Perkal H; Rovira A; Tintoré M
Mult Scler; 2010 Jan; 16(1):55-61. PubMed ID: 19995838
[TBL] [Abstract][Full Text] [Related]
40. Evoked response study among Malaysian multiple sclerosis patients.
Tan CT; Leong S
Singapore Med J; 1992 Dec; 33(6):575-80. PubMed ID: 1488664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
